CYRX News and Press, CryoPort Inc. From 07/01/21

Risk-reward tradeoffs and net payoffs offered by this group are better than those of most S&P 500 Index stocks and of many other Market-Maker [MM] forecast securities. They also outdo the prospects of many stocks widely held by Seeking Alpha readers, contributors, and commenters. ...

Cellenkos, a privately held, clinical-stage biotechnology company has selected Cryoport (CYRX) to provide “staged, on-demand, logistics solution for COVID-19 therapy shipments for patients.”Three of its companies, Cryoport Systems, CRYOPDP, and CRYOGENE will work in concert to &...

Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need PR Newswire NASHVILLE, Tenn. , June 22, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in tempera...

At 2021 Russell indexes annual reconstitution, following industrial stocks will be added to and deleted from the Russell Microcap Index.Additions include: Freightcar America (RAIL), Fuel Tech (FTEK), Ideanomics (IDEX), Izea Worldwide (IZEA), Lightbridge (LTBR),&#...

Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore CRYOPDP named Best Clinical Trial Logistics Provider at the Asia Pacific Bioprocessing Excellence Awards 2021 PR Newswire NASHVILLE, Tenn. , May 19, 2021 /PRNew...

Cryoport (CYRX) expands its global supply chain network with the acquisition of F-Airgate, a provider of temperature-controlled supply chain solutions, headquartered in Brussels, Belgium.The financial terms were not disclosed.The acquisition will expand Cryoport's presence in the EMEA region ...

Cryoport Expands Global Supply Chain Network with Belgium Acquisition Acquisition will expand Cryoport's presence in the EMEA region and is expected to be immediately accretive PR Newswire NASHVILLE, Tenn. , May 18, 2021 /PRNewswire/ -- Cryoport, Inc. ...

LabConnect and Cryoport Partner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial PR Newswire JOHNSON CITY, Tenn. and NASHVILLE, Tenn. , May 6, 2021 /PRNewswire/ -- LabConnect, Inc. and Cryoport, Inc. (NASDAQ: ...

Cryoport, Inc. (CYRX) Q1 2021 Results Conference Call May 04, 2021 05:00 PM ET Company Participants Todd Fromer - Managing Partner, KCSA Jerrell Shelton - CEO Robert Stefanovich - CFO Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP, Corporate Development and IR Conference Call...

CryoPort (CYRX): Q1 GAAP EPS of -$0.13 beats by $0.09.Revenue of $53.28M (+445.3% Y/Y) beats by $6.5M.Shares +1.4%.Press Release For further details see: CryoPort EPS beats by $0.09, beats on revenue